Literature DB >> 30213853

Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors.

Hardeep P Singh1,2, Sijia Wang1,2,3, Kevin Stachelek1,2,4, Sunhye Lee1,2, Mark W Reid1,2, Matthew E Thornton5, Cheryl Mae Craft6,7, Brendan H Grubbs5, David Cobrinik8,2,3,6,9,10.   

Abstract

Most retinoblastomas initiate in response to the inactivation of the RB1 gene and loss of functional RB protein. The tumors may form with few additional genomic changes and develop after a premalignant retinoma phase. Despite this seemingly straightforward etiology, mouse models have not recapitulated the genetic, cellular, and stage-specific features of human retinoblastoma genesis. For example, whereas human retinoblastomas appear to derive from cone photoreceptor precursors, current mouse models develop tumors that derive from other retinal cell types. To investigate the basis of the human cone-specific oncogenesis, we compared developmental stage-specific cone precursor responses to RB loss in human and murine retina cultures and in cone-specific Rb1-knockout mice. We report that RB-depleted maturing (ARR3+) but not immature (ARR3-) human cone precursors enter the cell cycle, proliferate, and form retinoblastoma-like lesions with Flexner-Wintersteiner rosettes, then form low or nonproliferative premalignant retinoma-like lesions with fleurettes and p16INK4A and p130 expression, and finally form highly proliferative retinoblastoma-like masses. In contrast, in murine retina, only RB-depleted immature (Arr3-) cone precursors entered the cell cycle, and they failed to progress from S to M phase. Moreover, whereas intrinsically highly expressed MDM2 and MYCN contribute to RB-depleted maturing (ARR3+) human cone precursor proliferation, ectopic MDM2 and Mycn promoted only immature (Arr3-) murine cone precursor cell-cycle entry. These findings demonstrate that developmental stage-specific as well as species- and cell type-specific features sensitize to RB1 inactivation and reveal the human cone precursors' capacity to model retinoblastoma initiation, proliferation, premalignant arrest, and tumor growth.

Entities:  

Keywords:  cancer cell of origin; cone photoreceptor; genetically engineered mouse models; retinoblastoma; retinoma

Mesh:

Substances:

Year:  2018        PMID: 30213853      PMCID: PMC6176579          DOI: 10.1073/pnas.1808903115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

1.  Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

Authors:  R Sears; F Nuckolls; E Haura; Y Taya; K Tamai; J R Nevins
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

2.  In vitro explant culture and related protocols for the study of mouse retinal development.

Authors:  Kangxin Jin; Mengqing Xiang
Journal:  Methods Mol Biol       Date:  2012

3.  Cell differentiation in the retina of the mouse.

Authors:  R W Young
Journal:  Anat Rec       Date:  1985-06

4.  Rb regulates fate choice and lineage commitment in vivo.

Authors:  Eliezer Calo; Jose A Quintero-Estades; Paul S Danielian; Simona Nedelcu; Seth D Berman; Jacqueline A Lees
Journal:  Nature       Date:  2010-08-04       Impact factor: 49.962

5.  Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry.

Authors:  Julien Sage; Abigail L Miller; Pedro A Pérez-Mancera; Julianne M Wysocki; Tyler Jacks
Journal:  Nature       Date:  2003-07-10       Impact factor: 49.962

Review 6.  Retinoblastoma.

Authors:  Helen Dimaras; Timothy W Corson; David Cobrinik; Abby White; Junyang Zhao; Francis L Munier; David H Abramson; Carol L Shields; Guillermo L Chantada; Festus Njuguna; Brenda L Gallie
Journal:  Nat Rev Dis Primers       Date:  2015-08-27       Impact factor: 52.329

7.  Expression of photoreceptor-associated molecules during human fetal eye development.

Authors:  Keely M Bumsted O'Brien; Dorothea Schulte; Anita E Hendrickson
Journal:  Mol Vis       Date:  2003-08-28       Impact factor: 2.367

8.  RB deletion disrupts coordination between DNA replication licensing and mitotic entry in vivo.

Authors:  Ryan J Bourgo; Ursula Ehmer; Julien Sage; Erik S Knudsen
Journal:  Mol Biol Cell       Date:  2011-02-02       Impact factor: 4.138

9.  Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences.

Authors:  B O Williams; E M Schmitt; L Remington; R T Bronson; D M Albert; R A Weinberg; T Jacks
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

10.  BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.

Authors:  Gregory M Shackleford; Xiang-He Shi; Kimberly S Swanson; Min Y Mahdi; Ignacio Gonzalez-Gomez; Shahab Asgharzadeh; Massimo D'Apuzzo; Anat Erdreich-Epstein; Rex A Moats
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

View more
  18 in total

1.  An immature, dedifferentiated, and lineage-deconstrained cone precursor origin of N-Myc-initiated retinoblastoma.

Authors:  Hardeep P Singh; Dominic W H Shayler; G Esteban Fernandez; Matthew E Thornton; Cheryl Mae Craft; Brendan H Grubbs; David Cobrinik
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-08       Impact factor: 12.779

2.  MYCN induces cell-specific tumorigenic growth in RB1-proficient human retinal organoid and chicken retina models of retinoblastoma.

Authors:  Maria K E Blixt; Minas Hellsand; Dardan Konjusha; Hanzhao Zhang; Sonya Stenfelt; Mikael Åkesson; Nima Rafati; Tatsiana Tararuk; Gustav Stålhammar; Charlotta All-Eriksson; Henrik Ring; Finn Hallböök
Journal:  Oncogenesis       Date:  2022-06-21       Impact factor: 6.524

3.  A novel thyroid hormone receptor isoform, TRβ2-46, promotes SKP2 expression and retinoblastoma cell proliferation.

Authors:  Zhengke Li; Dong-Lai Qi; Hardeep P Singh; Yue Zou; Binghui Shen; David Cobrinik
Journal:  J Biol Chem       Date:  2019-01-14       Impact factor: 5.157

4.  Tumor Environment of Retinoblastoma, Intraocular Cancer.

Authors:  Dong Hyun Jo; Jin Hyoung Kim; Jeong Hun Kim
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

5.  Variability in retinoblastoma genome stability is driven by age and not heritability.

Authors:  Ashley Polski; Liya Xu; Rishvanth K Prabakar; Xiaowu Gai; Jonathan W Kim; Rachana Shah; Rima Jubran; Peter Kuhn; David Cobrinik; James Hicks; Jesse L Berry
Journal:  Genes Chromosomes Cancer       Date:  2020-06-09       Impact factor: 5.006

Review 6.  Metabolic and Redox Signaling of the Nucleoredoxin-Like-1 Gene for the Treatment of Genetic Retinal Diseases.

Authors:  Emmanuelle Clérin; Myriam Marussig; José-Alain Sahel; Thierry Léveillard
Journal:  Int J Mol Sci       Date:  2020-02-27       Impact factor: 5.923

Review 7.  Functional Genomics of the Retina to Elucidate its Construction and Deconstruction.

Authors:  Frédéric Blond; Thierry Léveillard
Journal:  Int J Mol Sci       Date:  2019-10-04       Impact factor: 5.923

8.  Comprehensive Somatic Copy Number Analysis Using Aqueous Humor Liquid Biopsy for Retinoblastoma.

Authors:  Mary E Kim; Ashley Polski; Liya Xu; Rishvanth K Prabakar; Chen-Ching Peng; Mark W Reid; Rachana Shah; Peter Kuhn; David Cobrinik; James Hicks; Jesse L Berry
Journal:  Cancers (Basel)       Date:  2021-07-03       Impact factor: 6.639

Review 9.  Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays.

Authors:  Thilo M Buck; Jan Wijnholds
Journal:  Int J Mol Sci       Date:  2020-06-12       Impact factor: 5.923

10.  Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma.

Authors:  Santiago Zugbi; Daiana Ganiewich; Arpita Bhattacharyya; Rosario Aschero; Daniela Ottaviani; Claudia Sampor; Eduardo G Cafferata; Marcela Mena; Mariana Sgroi; Ursula Winter; Gabriela Lamas; Mariona Suñol; Manuel Daroqui; Edgardo Baialardo; Beatriz Salas; Anirban Das; Adriana Fandiño; Jasmine H Francis; Fabiana Lubieniecki; Cinzia Lavarino; Ralph Garippa; Osvaldo L Podhajcer; David H Abramson; François Radvanyi; Guillermo Chantada; Andrea S Llera; Paula Schaiquevich
Journal:  Cancers (Basel)       Date:  2020-09-22       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.